Sino Biological, Inc. reposted this
Unlock breakthrough research with Sino Biological, Inc.! 🔓 https://lnkd.in/gZiDZmFT
Sino Biological, headquartered in Beijing, China, is a global leader in recombinant protein and antibody production, gene synthesis, and CRO services for life sciences research and drug development. Its facilities include the Center for Bioprocessing (C4B) in Houston, Texas, which specializes in mammalian cell-based protein and antibody production, and SignalChem Biotech (SCB) in Vancouver, Canada, focusing on kinase-related reagents, stable cell line development, and therapeutic discovery. With a U.S. office providing localized support, Sino Biological ensures innovative, high-quality solutions for global academic and industrial clients.
External link for Sino Biological, Inc.
Sino Biological, Inc. reposted this
Unlock breakthrough research with Sino Biological, Inc.! 🔓 https://lnkd.in/gZiDZmFT
👨🔬We are proud to sponsor an upcoming webinar featuring Dr. Tyler B. Evans, MD, MS, MPH, DTMH, FIDSA, CEO and Co-Founder of Wellness Equity Alliance. Drawing on over two decades of global pandemic response, Dr. Evans will discuss how progress in vaccines, antivirals, and diagnostics must be matched with a commitment to equity and access. Join this important discussion on how scientific innovation and social responsibility can work together to strengthen global health outcomes. ⭐ Register Here: https://ow.ly/Ziuo50XcHfb #Webinar #PublicHealth #Virology #GlobalHealth #EquityInScience #VaccineResearch #HealthInnovation
Sino Biological, Inc. reposted this
Every diagnostic developer knows this struggle: you can spend months and tons of money testing antibody combinations, only to find that none produce a clean signal on your strip. One of the hardest parts of building a reliable lateral flow assay isn’t the device: it’s the biology. Antibodies must bind the right epitopes, stay stable during drying, and perform consistently between batches. But, Sino Biological, Inc. and SignalChem Biotech steps in to help you. We have ready-to-use LFA antibody pairs that detect key targets such as: - Viral antigens (e.g., Monkeypox, Influenza A/B, RSV, SARS-CoV-2) - Inflammatory markers (IL-2, IL-6, IL-8, IL-17, TNF) - Cancer biomarkers (CEA, CEACAM5, AFP) All with picogram-level detection sensitivity, comprehensive validation via negative samples, batch-to-batch reproducibility, compatibility with colloidal gold and time-resolved fluorescence systems. Contact us with a direct message on LinkedIn or email us at order@sinobiological.com Or learn more at: https://lnkd.in/gheWvCFu
Here's a recap of Advanced Lateral Flow Conference 2025 in La Jolla! 🎉 Our Sino Biological Team had a chance to... 💠Have insightful discussions 💠See innovative presentations 💠Network with many great industry professionals It was amazing to be part of this year's conference! #ALFC2025 #LateralFlow #RapidDiagnostics #PointOfCare #IVD #DiagnosticsDevelopment #MedTech #HealthTech #LifeSciences #Biotech #RegulatoryAffairs #SanDiego
🌟Last but not least, today's AiPAT 2025 speaker spotlight is our very own Rob Burgess, Chief Business Officer at Sino Biological, Inc. In his session, he will discuss Accelerating AI-Driven Antibody Discovery with Cell-Free Protein Synthesis, sharing insights on how cutting-edge technologies are transforming biologics research and discovery. We can’t wait—AiPAT 2025 kicks off in just 3 days! #SpeakerSpotlight #AiPAT2025 #Biotech #AIinTherapeutics #AntibodyDiscovery #CellFreeProteinSynthesis #Innovation #SinoBiological
We’re honored to welcome Dongxiao Feng, VP of Business Development at GenoBioTX, as one of our featured speakers at AiPAT 2025 ⭐ 👨🔬In his session, he will explore AI-assisted antibody building block fragmentation and function-oriented assembly of multispecific antibodies, offering fresh perspectives on how artificial intelligence is redefining the future of antibody engineering. We are excited to hear Dongxiao’s insights alongside other thought leaders shaping the next generation of therapeutic discovery! 🔗 Register here: https://ow.ly/5rPT50XaxHh #SpeakerSpotlight #AiPAT2025 #Biotech #AIinTherapeutics #AntibodyEngineering #Innovation #ProteinTherapeutics
⭐ We'll be at ALFC 2025 tomorrow! Come by and visit us at booth G11! 🧪
The ALFC 2025 exhibit floor is officially sold out! Strong demand from across rapid diagnostics filled every booth, but there are still ways to reach this highly targeted audience. A limited number of promotional opportunities remain for companies ready to showcase their products and services to 300+ diagnostics decision-makers in La Jolla and virtually. This year’s theme—Catalyzing Growth: Tech Advancements, Funding, and Regulatory Roadmaps in LFA—captures the momentum driving the industry forward. Link to the press release in the comments. #ALFC2025 #LateralFlow #RapidDiagnostics #RapidTesting #IVD #PointOfCare #HealthTech #MedTech #Diagnostics
🧪 Today we introduce Alfredo Quijano Rubio, Co-founder & CSO of Monod Bio, who will be a featured speaker at AiPAT 2025 — AI-Powered Innovation in Protein & Antibody Therapeutics. With his leadership in biologics R&D and innovation at Monod Bio, Alfredo brings a wealth of expertise in developing next-generation protein and antibody therapeutics. His work reflects a commitment to cutting-edge science and translational impact. 🤩 We’re looking forward to your insightful session! 🔗 Register here: https://ow.ly/xzgT50XaxBU
Sino Biological, Inc. reposted this
⏰ Happening tomorrow! Want to see how DNA-PAINT microscopy is redefining super-resolution imaging? 📅 Tuesday, Oct 14 🕘 7:00 AM PT · 10:00 AM ET · 16:00 CET Speaker: Kimberly Cramer, PhD (Massive Photonics) Learn how DNA-PAINT enables: Unlimited multiplexing Quantitative molecule counting Single-protein resolution 👉 Final chance to register: https://lnkd.in/gX2NTUDV #Microscopy #DrugDiscovery #Biotech
⭐ We’re delighted to introduce Alon Wellner, VP of Biology and Co-Founder at Aureka Biotechnologies, Inc. Biotechnologies, as a featured speaker at AiPAT 2025 — AI-Powered Innovation in Protein & Antibody Therapeutics. With a Ph.D. in Biochemistry and over seven years of experience in leading-edge molecular research, Dr. Wellner is advancing precision medicine through innovative, scalable solutions for previously untreatable therapeutic targets. See you at AiPAT 2025 to explore how AI is driving breakthroughs in protein and antibody therapeutics with leaders from academia and industry! 📅 October 18, 2025 | 📍 Crowne Plaza Foster City, CA 🔗 Register here: https://ow.ly/ApKV50X8AFM